Keywords: galapagos, zobio, pyxis, leiden, university, enter, arthritis

Galapagos, ZoBio, Pyxis and Leiden University enter arthritis R&D accord

Article | 15 August 2005

Belgian genomics-based drugmaker Galapagos NV, Dutch firms ZoBio BV and Pyxis Discovery BV, together with Leiden University, the Netherlands, have ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Drug Discovery

Go to company listing